(SGRY) Surgery Partners - Ratings and Ratios

Surgery Partners, Inc. operates a network of surgical facilities and ancillary services across the United States, providing a range of non-emergency surgical procedures in various specialties. The companys facilities offer a diverse set of services, including orthopedics, pain management, ophthalmology, gastroenterology, and general surgery, catering to a broad patient base. Additionally, Surgery Partners provides emergency departments, multi-specialty physician practices, urgent care facilities, and anesthesia services, making it a comprehensive healthcare provider.

The companys business model is centered around ambulatory surgery centers and surgical hospitals, which are designed to provide efficient and cost-effective surgical care. With a presence in multiple locations, Surgery Partners is well-positioned to capitalize on the growing demand for outpatient surgical procedures. The companys ancillary services, such as physician practices and urgent care facilities, further enhance its revenue streams and contribute to its growth prospects.

Analyzing the , we observe that the stock has been trading around its 20-day Simple Moving Average (SMA) of $23.19, with a current price of $23.10. The 50-day SMA is at $22.41, indicating a potential support level, while the 200-day SMA is at $25.17, suggesting a longer-term resistance level. The Average True Range (ATR) is 0.61, representing a 2.63% daily price movement. Given the current price action and the proximity to the 52-week high of $33.69 and low of $19.61, we can anticipate potential price movements based on the stocks historical volatility.

From a fundamental perspective, Surgery Partners has a market capitalization of $3.025 billion and a forward Price-to-Earnings (P/E) ratio of 17.51. The companys Return on Equity (RoE) is currently negative at -10.48%, indicating potential challenges in generating profits. However, the forward P/E ratio suggests that investors are expecting improved earnings in the future. By combining the technical and fundamental analysis, we can forecast that Surgery Partners may experience a price increase if it can demonstrate improved earnings and stabilize its RoE. A potential target price could be around $28-30, based on the stocks historical price movements and the current fundamental outlook.

Forecasting the future performance of SGRY involves considering both the technical indicators and fundamental data. If the stock can break above the 200-day SMA and sustain its price above $25.17, it may be a bullish signal, potentially driving the price towards the 52-week high. Conversely, if the stock fails to gain traction and falls below the 50-day SMA, it may experience a decline towards the 52-week low. By closely monitoring the companys earnings reports, industry trends, and technical indicators, investors can make informed decisions about their investment in SGRY.